The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
<p dir="ltr">The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. Here we report a cohort of 86 acute myeloid leukemia (AML) an...
Saved in:
Similar Items
-
Ecthyma gangrenosum: a rare manifestation of Stenotrophomonas maltophilia infection in acute myelogenous leukemia patient
by: Gawahir A. Ali (14777260)
Published: (2021) -
Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes
by: Halima El Omri (14778790)
Published: (2020) -
Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
by: Mahmoud M. Morsy (18560491)
Published: (2024) -
Investigation of Genetic Causes in Patients with Congenital Heart Disease in Qatar: Findings from the Sidra Cardiac Registry
by: Sarah Okashah (18282262)
Published: (2022) -
Increasing methylation of sperm rDNA and other repetitive elements in the aging male mammalian germline
by: Ramya Potabattula (4401160)
Published: (2020)